GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,049,000 | -6.4% | 75,120 | -0.6% | 0.58% | -10.8% |
| Q2 2017 | $3,259,000 | +4.7% | 75,577 | +2.4% | 0.66% | +2.7% |
| Q1 2017 | $3,112,000 | +13.5% | 73,823 | +3.7% | 0.64% | +11.7% |
| Q4 2016 | $2,741,000 | -12.5% | 71,214 | -2.0% | 0.57% | -17.8% |
| Q3 2016 | $3,134,000 | +18.5% | 72,654 | +19.1% | 0.70% | +12.8% |
| Q2 2016 | $2,645,000 | +28.9% | 61,013 | +20.5% | 0.62% | +19.8% |
| Q1 2016 | $2,052,000 | +1.6% | 50,625 | +1.1% | 0.51% | +2.0% |
| Q4 2015 | $2,020,000 | +52.8% | 50,077 | +45.7% | 0.50% | +41.2% |
| Q3 2015 | $1,322,000 | -4.0% | 34,369 | +3.9% | 0.36% | +1.7% |
| Q2 2015 | $1,377,000 | -5.4% | 33,070 | +4.8% | 0.35% | -5.4% |
| Q1 2015 | $1,456,000 | +36.8% | 31,548 | +26.7% | 0.37% | +34.4% |
| Q4 2014 | $1,064,000 | +56.0% | 24,903 | +67.8% | 0.28% | +52.5% |
| Q3 2014 | $682,000 | – | 14,844 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |